- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19:26 | Roche rolls out new DNA 'sequencing-by-expansion' approach | ||
| 17:26 | Procedural 'loophole' leaves NIH grants frozen, despite orders from federal judge: reports | ||
| 17:26 | MeiraGTx gene therapy allows 11 blind children to see as biotech eyes accelerated approval | ||
| 14:26 | Concentra curveball offer throws Acelyrin merger with Alumis into doubt | ||
| Do | US biotech Hookipa retracts merger plans with UK company | ||
| Do | Heart monitoring patch maker VitalConnect raises $100M | ||
| Do | Illumina maps out entry into spatial transcriptomics | ||
| Do | German research institute teams up with Barbados to improve cardiometabolic treatments for Black individuals | ||
| Do | IconOVir, 4 years on from flashy launch, sells oncolytic virus to UroGen for $4M in stock | ||
| Do | Incyte pens $885M biobucks AI pact to use Genesis' GEMS to develop new drugs | ||
| Mi | It's curtain close for Spotlight: Gene editing biotech shutters | ||
| Mi | Deep Track nominates candidates for Dynavax's board, launching proxy fight to end company's 'empire-building' strategy | ||
| Mi | Altitude Lab sources funding, lab space for biotechs concerned about fate of NIH grants | ||
| Mi | Cabaletta's CAR-T shows 'robust benefit' in lupus patients, teeing up registrational trial plans | ||
| Mi | Siemens Healthineers plans 'mega depots' to bolster US supply chain amid 'geopolitical uncertainties' | ||
| Mi | Ascletis' swift surge into obesity continues with competitive oral GLP-1 data | ||
| Mi | Australian biotech points to potential superbug use as gel treats skin infections in phase 2 trial | ||
| Mi | Radiance rolls into ROR1 race, paying $15M for ADC rival to Merck's frontrunner | ||
| Mi | Merck pens $300M-per-product collab with Epitopea to locate 'hidden' tumor antigens | ||
| Di | Novo Nordisk to sue KBP Biosciences over alleged fraudulent claims on kidney disease drug | ||
| Di | Trump administration layoffs hit FDA's device center | ||
| Di | J&J MedTech restarts Varipulse's US rollout after stroke reports | ||
| Di | 2 NIH leaders depart as White House cuts thousands of jobs across federal health agencies | ||
| Di | Septerna drops lead asset over bilirubin side effects 4 months after going public | ||
| Di | Biogen pays Stoke $165M, bagging Dravet prospect to fire up late-phase pipeline |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
